EXHIBIT 99
This Current Report on Form 8-K is being furnished to include supplemental unaudited historical information that was updated as a result of the following:
Changes in the measure of segment operating performance used by 3M’s chief operating decision maker impacting 3M’s segment reporting.
Changes to non-GAAP measures - certain amounts adjusted for special items, adjusted free cash flow, adjusted free cash flow conversion, and adjusted EBITDA. The information reflects expanding the extent of special item adjustments to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products.

The Company did not operate using the new measure of segment operating performance until the first quarter of 2023 and will begin to report comparative results under this basis with the filing of its Quarterly Report on Form 10-Q for the quarter ending March 31, 2023. Until 3M’s interim financial statements as of and for the quarter ending March 31, 2023 are issued, amounts on the updated basis are not in accordance with U.S. GAAP and, as a result, are considered non-GAAP measures.
The Company is furnishing this information as it believes it is useful to investors to aid in understanding, on a timely basis, the impacts of these changes on historical periods as they prepare to consider 3M’s future results on the updated basis.
As used herein, the term “3M” or “Company” includes 3M Company and its subsidiaries unless the context indicates otherwise. The information contained in this Current Report shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, or the Exchange Act.
Changes in the measure of segment operating performance used by 3M’s chief operating decision maker (CODM)
Note 19 to 3M’s consolidated financial statements in its 2022 Annual Report on Form 10-K describes 3M’s business segments and measure of segment operating performance used by 3M’s CODM.
Effective in the first quarter of 2023, the measure of segment operating performance used by 3M’s CODM changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income) will be updated for all comparative periods presented. The change to business segment sales and operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company’s business segments. The changes included the following:
Reflecting gains/losses from sale of property, plant and equipment (PPE) and other assets within Corporate and Unallocated Change
3M updated its business segment operating performance measure to reflect all gains/losses from sales of PPE and other assets within Corporate and Unallocated. Previously, certain of these gains/losses were included in 3M’s business segments’ operating performance. In aggregate, for example relative to 2022, this change included ascribing approximately $135 million of gains previously included in the various business segments to Corporate and Unallocated as further reflected in the tables that follow.
Movement of certain businesses between segments
The businesses associated with two groups of products (each with approximately $25 million in sales) were realigned with one moving from the Consumer business segment to the Health Care business segment and the other moving from the Health Care business segment to the Consumer business segment.
Also effective in the first quarter of 2023, the Consumer business re-aligned from four divisions to the following three divisions: Home, Health and Auto Care; Construction and Home Improvement Markets; and Stationery and Office.
The tables below provide additional information with respect to the expected impact of the changes described above on previously reported segment and disaggregated revenue information. 3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. 
4

EXHIBIT 99
Updated Basis (non-GAAP measure)*Total Year
Net Sales (Millions)First QuarterSecond QuarterThird QuarterFourth QuarterPreviously ReportedImpact of ChangesUpdated basis (non-GAAP measure)*
Safety and Industrial
2022$3,051 $2,924 $2,894 $2,735 $11,604 $— $11,604 
20213,099 3,029 3,005 2,848 11,981 — 11,981 
202010,972 — 10,972 
Transportation and Electronics
2022$2,340 $2,268 $2,239 $2,055 $8,902 $— $8,902 
20212,396 2,355 2,327 2,184 9,262 — 9,262 
20208,406 — 8,406 
Health Care
2022$2,128 $2,179 $2,076 $2,044 $8,421 $$8,427 
20212,071 2,166 2,173 2,191 8,597 8,601 
20207,832 7,835 
Consumer
2022$1,309 $1,330 $1,409 $1,244 $5,298 $(6)$5,292 
20211,287 1,399 1,434 1,389 5,513 (4)5,509 
20204,976 (3)4,973 
Corporate and Unallocated
2022$$$$$$— $
2021(2)— — 
2020(2)— (2)
Total Company
2022$8,829 $8,702 $8,619 $8,079 $34,229 $— $34,229 
20218,851 8,950 8,942 8,612 35,355 — 35,355 
202032,184 — 32,184 
*     Amounts reflect first quarter of 2023 changes in measure of segment operating performance as described herein. Until 3M’s interim financial statements as of and for the quarter ending March 31, 2023 are issued, amounts on the updated basis are not in accordance with U.S. GAAP and, as a result, are considered non-GAAP measures.
5

EXHIBIT 99
Updated Basis (non-GAAP measure)*Total Year
Operating Performance (millions)First QuarterSecond QuarterThird QuarterFourth QuarterPreviously ReportedImpact of ChangesUpdated basis (non-GAAP measure)*
Safety and Industrial
2022$627 $(707)$652 $563 $1,199 $(64)$1,135 
2021747 661 563 489 2,466 (6)2,460 
20202,588 (56)2,532 
Transportation and Electronics
2022$464 $475 $475 $(441)$1,012 $(39)$973 
2021555 506 435 373 1,880 (11)1,869 
20201,701 (11)1,690 
Health Care
2022$445 $492 $450 $412 $1,815 $(16)$1,799 
2021465 547 508 514 2,037 (3)2,034 
20201,662 (1)1,661 
Consumer
2022$219 $248 $299 $212 $994 $(16)$978 
2021268 291 310 295 1,162 1,164 
20201,119 (2)1,117 
Total business segment operating income
2022$1,755 $508 $1,876 $746 $5,020 $(135)$4,885 
20212,035 2,005 1,816 1,671 7,545 (18)7,527 
20207,070 (70)7,000 
Corporate and Unallocated
2022$(114)$(398)$2,280 $(114)$1,519 $135 $1,654 
2021(41)(34)(28)(55)(176)18 (158)
202091 70 161 
Total Company operating income
2022$1,641 $110 $4,156 $632 $6,539 $— $6,539 
20211,994 1,971 1,788 1,616 7,369 — 7,369 
20207,161 — 7,161 
Other expense/(income), net
2022$147 $— $147 
2021165 — 165 
2020366 — 366 
Income before income taxes
2022$6,392 $— $6,392 
20217,204 — 7,204 
20206,795 — 6,795 
6

EXHIBIT 99
Disaggregated revenue information
Updated Basis (non-GAAP measure)*
Year ended December 31,
Net Sales (Millions)202220212020
Abrasives$1,343 $1,296 $1,077 
Automotive Aftermarket1,209 1,164 1,028 
Closure and Masking Systems1,046 1,033 993 
Electrical Markets1,304 1,229 1,093 
Industrial Adhesives and Tapes2,331 2,353 2,000 
Personal Safety3,916 4,470 4,408 
Roofing Granules455 428 389 
Other Safety and Industrial— (16)
Total Safety and Industrial Business Segment11,604 11,981 10,972 
Advanced Materials1,205 1,200 1,029 
Automotive and Aerospace1,754 1,756 1,522 
Commercial Solutions1,751 1,717 1,486 
Electronics3,359 3,673 3,497 
Transportation Safety833 907 880 
Other Transportation and Electronics— (8)
Total Transportation and Electronics Business Segment8,902 9,262 8,406 
Drug Delivery— — 146 
Food Safety244 368 337 
Health Information Systems1,259 1,220 1,140 
Medical Solutions4,581 4,632 4,288 
Oral Care1,327 1,396 1,052 
Separation and Purification Sciences992 984 870 
Other Health Care24 
Total Health Care Business Group8,427 8,601 7,835 
Home, Health and Auto Care1,655 1,741 1,649 
Construction and Home Improvement Markets2,346 2,465 2,191 
Stationery and Office1,291 1,306 1,132 
Other Consumer— (3)
Total Consumer Business Group5,292 5,509 4,973 
Corporate and Unallocated(2)
Total Company$34,229 $35,355 $32,184 
7

EXHIBIT 99
Changes to Non-GAAP Measures - Certain Amounts Adjusted for Special Items, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion, and Adjusted EBITDA
In 2023, 3M is changing certain of its non-GAAP measures by adjusting for the results of manufactured PFAS products in arriving at results, adjusted for special items. In the fourth quarter of 2022, 3M record a charge for PFAS manufacturing exit costs and included it as an adjustment in arriving at results, adjusted for special items. The 2023 non-GAAP measure change involves expanding the extent of adjustment to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025. This change also impacts other non-GAAP measures such as adjusted free cash flow, adjusted free cash flow conversion and adjusted EBITDA to similarly include relevant special item adjustments for manufactured PFAS products.
The discussion and tables below include information with respect to historical amounts adjusted for special items (non-GAAP measures) reflective of the changes in measure of segment operating performance and non-GAAP measures described above.
Certain amounts adjusted for special items - (non-GAAP measures):

Year ended December 31, 2020
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3M Earnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$2,532 23.1 %
Adjustments for special items:
Net costs for significant litigation205 
Total special items205 
Adjusted amounts (non-GAAP measures) (a)
$2,737 25.0 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$8,406 $1,690 20.1 %
Adjustments for special items:
Manufactured PFAS products(1,063)(108)
Total special items(1,063)(108)
Adjusted amounts (non-GAAP measures) (a)
$7,343 $1,582 21.5 %
Total Company
Updated basis (non-GAAP measure)*$32,184 $7,161 22.3 %$6,795 $1,337 19.7 %$5,449 $9.36 
Adjustments for special items:
Net costs for significant litigation— 353 353 136 217 0.37 
Manufactured PFAS products(1,063)(108)(108)(23)(85)(0.15)
Gain on business divestitures— (389)(389)(86)(303)(0.52)
Divestiture-related restructuring actions— 55 55 46 0.08 
Total special items(1,063)(89)(89)36 (125)(0.22)
Adjusted amounts (non-GAAP measures) (a)
$31,121 $7,072 22.7 %$6,706 $1,373 20.5 %$5,324 $9.14 
8

EXHIBIT 99
Year ended December 31, 2021
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$2,460 20.5 %
Adjustments for special items:
Net costs for significant litigation249 
Total special items249 
Adjusted amounts (non-GAAP measures) (a)
$2,709 22.6 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$9,262 $1,869 20.2 %
Adjustments for special items:
Manufactured PFAS products(1,258)(135)
Total special items(1,258)(135)
Adjusted amounts (non-GAAP measures) (a)
$8,004 $1,734 21.7 %
Total Company
Updated basis (non-GAAP measure)*$35,355 $7,369 20.8 %$7,204 $1,285 17.8 %$5,921 $10.12 
Adjustments for special items:
Net costs for significant litigation— 463 $463 $104 $359 0.61 
Manufactured PFAS products(1,258)(135)$(135)$(29)$(106)(0.18)
Total special items(1,258)328 $328 $75 $253 0.43 
Adjusted amounts (non-GAAP measures (a)
$34,097 $7,697 22.6 %$7,532 $1,360 18.1 %$6,174 $10.55 
Year ended December 31, 2022
(Dollars in millions, except per share amounts)SalesSales ChangeOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted ShareEarnings per diluted share percent change
Safety and Industrial
Updated basis (non-GAAP measure)*$1,1359.8 %
Adjustments for special items:
Net costs for significant litigation1,414
Total special items1,414
Adjusted amounts (non-GAAP measures) (a)
$2,54922.0 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$8,902 (3.9)%$973 10.9 %
Adjustments for special items:
Manufactured PFAS products(1,351)631 
Total special items(1,351)631 
Adjusted amounts (non-GAAP measures) (a)
$7,551 (5.6)%$1,604 21.2 %
Total Company
Updated basis (non-GAAP measure)*$34,229 (3.2)%$6,539 19.1 %$6,392 $612 9.6 %$5,777 10.18 %
Adjustments for special items:
Net costs for significant litigation— 2,291 2,291 476 1,815 3.20 
Manufactured PFAS products(1,351)631 631 121 510 0.90 
Gain on business divestitures— (2,724)(2,724)(39)(2,685)(4.73)
Divestiture-related restructuring actions— 41 41 32 0.05 
Divestiture costs— 60 60 13 47 0.08 
Russia exit charges— 109 109 (2)111 0.20 
Total special items(1,351)408 408 578 (170)(0.30)
Adjusted amounts (non-GAAP measures) (a)
$32,878 (3.6)%$6,947 21.1 %$6,800 $1,190 17.5 %$5,607 $9.88 (6)%
9

EXHIBIT 99
Three months ended March 31, 2021
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$74724.1 %
Adjustments for special items:
Net costs for significant litigation65
Total special items65
Adjusted amounts (non-GAAP measures) (a)
$81226.2 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,396 $555 23.2 %
Adjustments for special items:
Manufactured PFAS products(331)(34)
Total special items(331)(34)
Adjusted amounts (non-GAAP measures) (a)
$2,065 $521 25.3 %
Total Company
Updated basis (non-GAAP measure)*$8,851 $1,994 22.5 %$1,945 $319 16.4 %$1,624 2.77 
Adjustments for special items:
Net costs for significant litigation— 135 135 32 103 0.18 
Manufactured PFAS products(331)(34)(34)(8)(26)(0.05)
Total special items(331)101 101 24 77 0.13 
Adjusted amounts (non-GAAP measures) (a)
$8,520 $2,095 24.6 %$2,046 $343 16.8 %$1,701 $2.90 
Three months ended March 31, 2022
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$62720.6 %
Adjustments for special items:
Net costs for significant litigation63
Total special items63
Adjusted amounts (non-GAAP measures) (a)
$69022.6 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,340 $464 19.8 %
Adjustments for special items:
Manufactured PFAS products(320)(16)
Total special items(320)(16)
Adjusted amounts (non-GAAP measures) (a)
$2,020 $448 22.2 %
Total Company
Updated basis (non-GAAP measure)*$8,829 $1,641 18.6 %$1,603 $302 18.8 %$1,299 2.26 
Adjustments for special items:
Net costs for significant litigation— 250 250 25 225 0.39 
Manufactured PFAS products(320)(16)(16)(4)(12)(0.02)
Total special items(320)234 234 21 213 0.37 
Adjusted amounts (non-GAAP measures) (a)
$8,509 $1,875 22.0 %$1,837 $323 17.5 %$1,512 $2.63 
10

EXHIBIT 99
Three months ended June 30, 2021
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$66121.8 %
Adjustments for special items:
Net costs for significant litigation52
Total special items52
Adjusted amounts (non-GAAP measures) (a)
$71323.6 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,355 $506 21.5 %
Adjustments for special items:
Manufactured PFAS products(323)(44)
Total special items(323)(44)
Adjusted amounts (non-GAAP measures) (a)
$2,032 $462 22.7 %
Total Company
Updated basis (non-GAAP measure)*$8,950 $1,971 22.0 %$1,938 $415 21.5 %$1,524 $2.59 
Adjustments for special items:
Net costs for significant litigation— 127 127 30 97 0.16 
Manufactured PFAS products(323)(44)(44)(10)(34)(0.05)
Total special items(323)83 83 20 63 0.11 
Adjusted amounts (non-GAAP measures) (a)
$8,627 $2,054 23.8 %$2,021 $435 21.6 %$1,587 $2.70 
Three months ended June 30, 2022
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$(707)(24.2)%
Adjustments for special items:
Net costs for significant litigation1,337
Total special items1,337
Adjusted amounts (non-GAAP measures) (a)
$63021.5 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,268 $475 21.0 %
Adjustments for special items:
Manufactured PFAS products(318)(20)
Total special items(318)(20)
Adjusted amounts (non-GAAP measures) (a)
$1,950 $455 23.4 %
Total Company
Updated basis (non-GAAP measure)*$8,702 $110 1.3 %$60 $(23)(38.3)%$78 $0.14 
Adjustments for special items:
Net costs for significant litigation— 1,716 1,716 374 1,342 2.34 
Manufactured PFAS products(318)(20)(20)(6)(14)(0.03)
Total special items(318)1,696 1,696 368 1,328 2.31 
Adjusted amounts (non-GAAP measures) (a)
$8,384 $1,806 21.6 %$1,756 $345 19.8 %$1,406 $2.45 
11

EXHIBIT 99
Three months ended September 30, 2021
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$56318.7 %
Adjustments for special items:
Net costs for significant litigation60
Total special items60
Adjusted amounts (non-GAAP measures) (a)
$62320.7 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,327 $435 18.7 %
Adjustments for special items:
Manufactured PFAS products(321)(49)
Total special items(321)(49)
Adjusted amounts (non-GAAP measures) (a)
$2,006 $386 19.2 %
Total Company
Updated basis (non-GAAP measure)*$8,942 $1,788 20.0 %$1,757 $324 18.4 %$1,434 2.45 
Adjustments for special items:
Net costs for significant litigation— 97 97 18 79 0.13 
Manufactured PFAS products(321)(49)(49)(11)(38)(0.06)
Total special items(321)48 48 41 0.07 
Adjusted amounts (non-GAAP measures) (a)
$8,621 $1,836 21.3 %$1,805 $331 18.4 %$1,475 $2.52 
Three months ended September 30, 2022
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$65222.5 %
Adjustments for special items:
Net costs for significant litigation21
Total special items21
Adjusted amounts (non-GAAP measures) (a)
$67323.2 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,239 $475 21.2 %
Adjustments for special items:
Manufactured PFAS products(350)(65)
Total special items(350)(65)
Adjusted amounts (non-GAAP measures) (a)
$1,889 $410 21.7 %
Total Company
Updated basis (non-GAAP measure)*$8,619 $4,156 48.2 %$4,132 $271 6.6 %$3,859 6.77 
Adjustments for special items:
Net costs for significant litigation— 267 267 57 210 0.37 
Manufactured PFAS products(350)(65)(65)(16)(49)(0.09)
Gain on business divestitures— (2,724)(2,724)(39)(2,685)(4.71)
Divestiture-related restructuring actions— 41 41 32 0.05 
Divestiture costs— 0.01 
Russia exit charges— 109 109 (2)111 0.20 
Total special items(350)(2,366)(2,366)11 (2,377)(4.17)
Adjusted amounts (non-GAAP measures) (a)
$8,269 $1,790 21.6 %$1,766 $282 15.9 %$1,482 $2.60 
12

EXHIBIT 99
Three months ended December 31, 2021
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$48917.2 %
Adjustments for special items:
Net costs for significant litigation72
Total special items72
Adjusted amounts (non-GAAP measures) (a)
$56119.7 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,184 $373 17.1 %
Adjustments for special items:
Manufactured PFAS products(283)(8)
Total special items(283)(8)
Adjusted amounts (non-GAAP measures) (a)
$1,901 $365 19.2 %
Total Company
Updated basis (non-GAAP measure)*$8,612 $1,616 18.8 %$1,564 $227 14.5 %$1,339 2.31 
Adjustments for special items:
Net costs for significant litigation— 104 104 24 80 0.14 
Manufactured PFAS products(283)(8)(8)— (8)(0.02)
Total special items(283)96 96 24 72 0.12 
Adjusted amounts (non-GAAP measures (a)
$8,329 $1,712 20.5 %$1,660 $251 15.0 %$1,411 $2.43 
Three months December 31, 2022
(Dollars in millions, except per share amounts)SalesOperating IncomeOperating Income MarginIncome Before TaxesProvision for Income TaxesEffective tax rateNet Income Attributable to 3MEarnings per Diluted Share
Safety and Industrial
Updated basis (non-GAAP measure)*$56320.6 %
Adjustments for special items:
Net costs for significant litigation(7)
Total special items(7)
Adjusted amounts (non-GAAP measures) (a)
$55620.4 %
Transportation and Electronics
Updated basis (non-GAAP measure)*$2,055 $(441)(21.4)%
Adjustments for special items:
Manufactured PFAS products(363)732 
Total special items(363)732 
Adjusted amounts (non-GAAP measures) (a)
$1,692 $291 17.1 %
Total Company
Updated basis (non-GAAP measure)*$8,079 $632 7.8 %$597 $62 10.5 %$541 0.98 
Adjustments for special items:
Net costs for significant litigation— 58 58 20 38 0.07 
Manufactured PFAS products(363)732 732 147 585 1.05 
Divestiture costs— 54 54 11 43 0.08 
Total special items(363)844 844 178 666 1.20 
Adjusted amounts (non-GAAP measures) (a)
$7,716 $1,476 19.1 %$1,441 $240 16.6 %$1,207 $2.18 

13

EXHIBIT 99
Year ended December 31, 2022
Sales Change (b)
Organic salesAcquisitionsDivestituresTranslationTotal sales change
Total Company1.2 %— %(0.5)%(3.9)%(3.2)%
Remove manufactured PFAS products impact(0.4)— — — (0.4)
Adjusted total Company (non-GAAP measures) (a)
0.8 %— %(0.5)%(3.9)%(3.6)%
Transportation and Electronics1.2 %— %(0.5)%(4.6)%(3.9)%
Remove manufactured PFAS products impact(2.2)— — 0.5 (1.7)
Adjusted Transportation and Electronics (non-GAAP measures) (a)
(1.0)%— %(0.5)%(4.1)%(5.6)%
(a)     In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. Net sales (and sales change), operating income, segment operating income, operating income margin, income before taxes, provision for income taxes, effective tax rate, net income, and earnings per share are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. The Company considers these non-GAAP measures in evaluating and managing its operations. The Company believes that discussion of results adjusted for special items is useful to investors in understanding underlying business performance, while also providing additional transparency to the special items. The determination of these items may not be comparable to similarly titled measures used by other companies.
(b)     Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction.
14

EXHIBIT 99
Adjusted free cash flow and adjusted free cash flow conversion (non-GAAP measures):

Year ended
December 31,
Major GAAP Cash Flow Categories (dollars in millions)2022
Net cash provided by (used in) operating activities$5,591 
Net cash provided by (used in) investing activities(1,046)
Net cash provided by (used in) financing activities(5,350)
Adjusted Free Cash Flow (non-GAAP measure)
(dollars in millions)
Year ended
December 31,
2022
Net cash provided by (used in) operating activities$5,591 
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts716 
Divestiture costs after-tax payment impacts
Divestiture gains - closing cost after tax payment impacts27 
Divestiture-related restructuring after-tax payment impacts28 
Russia exit charges after-tax payment impacts
TCJA transition tax payment68 
Manufactured PFAS products impact(36)
Total adjustments for special items813 
Adjusted net cash provided by (used in) operating activities (c)
6,404 
Purchases of property, plant and equipment (PPE)(1,749)
Manufactured PFAS products impact — removing related purchases of PPE175 
Adjusted free cash flow (c)
$4,830 
Adjusted net income attributable to 3M (a)
$5,607 
Adjusted free cash flow conversion (c)
86 %
(c)     Adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. The Company defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. Cash payments associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. The Company believes adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion all are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the Company and its ability to generate cash.
15

EXHIBIT 99
Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures):
Year ended December 31,
Adjusted EBITDA (non-GAAP measure) (dollars in millions)20222021
Adjusted net sales (a)
$32,878 $34,097 
Net income attributable to 3M5,777 5,921 
Add/(subtract):
Net income/(loss) attributable to noncontrolling interest14 
(Income)/loss from unconsolidated subsidiaries, net of taxes(11)(10)
Provision for income taxes612 1,285 
Other expense/(income):
Interest (income)/expense395 462 
Pension & OPEB non-service cost (benefit)(248)(297)
Depreciation and amortization (DA) expense1,831 1,915 
Adjustments for special items:
Net costs for significant litigation2,291 463 
Manufactured PFAS products impact:
Remove manufactured PFAS products operating (income) loss631 (135)
Subtract PFAS-related amount include in DA above(68)(56)
Gain on business divestitures(2,724)— 
Divestiture-related restructuring actions41 — 
Divestiture costs60 — 
Russia exit charges109 — 
Total special items340 272 
Adjusted EBITDA (d)
$8,710 $9,556 
Adjusted EBITDA margin (d)
26.5 %28.0 %
(d)     Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales, adjusted for special items. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. The Company considers these non-GAAP measures in evaluating and managing the Company’s operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends.
Description of Special Items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below. These items align with those included in the section “Supplemental Financial Information — Non-GAAP Measures, Description of Special Items” within the Form 8-K dated January 24, 2023 which is largely repeated below, with the exception of the expansion of the extent of adjustment relative to PFAS manufactured products to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025.
Net costs for significant litigation:
These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as corporate special items in Corporate and Unallocated. In 2022, 3M made payments of approximately $907 million related to net costs for significant litigation.
16

EXHIBIT 99
Divestiture costs:
These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. In the 2022, 3M made payments of approximately $11 million associated with divestiture costs.
Gain/loss on sale of businesses divestitures:
In 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of its Food Safety business with Neogen Corporation. In 2022, 3M made payments of approximately $34 million related to closing costs of the transaction that were part of the determination of the gain thereon.
Divestiture-related restructuring actions:
In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In 2022, 3M made payments of approximately $34 million and associated with divestiture-related restructuring actions.
Russia exit charges:
In 2022, 3M recorded a charge primarily related to impairment of net assets in Russia in connection with management’s committed exit and disposal plan. In 2022, 3M made payments of approximately $3 million related to Russia exit charges.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA)
In 2022, 3M made payments of approximately $68 million related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA.
Manufactured PFAS products:
These amounts relate to sales and estimates of income and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, and certain changes in working capital.
17